Latest Teratogens Stories
The revelations come amid a growing number of Xarelto lawsuits that, among other things, question the marketing tactics used to drive sales of the blood thinner. New
Right the Wrong Campaign seeks to educate Canadians on how a government approved drug left them with severe birth defects that challenge their lives to this day MONTREAL, Nov.
Anticoagulation Coalition Electronic Health Record Task Force provides List of EHR features for the delivery of optimized anticoagulation therapy ST. PAUL, Minn., Nov.
WOODCLIFF LAKE, N.J., Oct. 20, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.
September is Fetal Alcohol Spectrum Disorder Awareness Month HARRISBURG, Pa., Sept.
A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C.
Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin.
On July 1, the FDA published that 6 lots of Coumadin (Warfarin Sodium) for Injection, 5 mg single-use vials, by Bristol-Myers Squibb, are recalled due to the presence of visible particulate matter.
IPRO-designed "MAP" Tool Addresses How to Handle Numerous Patient Situations, In Order to Reduce Risk of Both Excessive Bleeding and Formation of Blood Clots LAKE SUCCESS, N.Y., May
- totally perplexed and mixed up.